Table 3.
Adjusted VE of PPV23 vaccination against pneumococcal diseases among people aged 60 years or older.
| Multivariable adjustments | Adjusted VE,% (95%CI) | P |
|---|---|---|
| Overall | ||
| Model 1 | 24 (3, 41) | 0.030 |
| Model 2 | 25 (4, 42) | 0.025 |
| Model 3 | 25 (3, 42) | 0.030 |
| Stratified by gender | ||
| Male | ||
| Model 1 | 17 (−11, 37) | 0.215 |
| Model 2 | 17 (−11, 38) | 0.203 |
| Model 3 | 17 (−11, 38) | 0.213 |
| Female | ||
| Model 1 | 47 (9, 70) | 0.023 |
| Model 2 | 50 (13, 72) | 0.015 |
| Model 3 | 49 (11, 71) | 0.019 |
Model 1: Adjusted for age, medical history (respiratory related diseases, chronic underlying diseases and immune system diseases) and smoking status.
Model 2: Adjusted for age, medical history (respiratory related diseases, chronic underlying diseases and immune system diseases), smoking status and co-infection with other pathogens.
Model 3: Adjusted for age, medical history (respiratory related diseases, chronic underlying diseases and immune system diseases), smoking status, co-infection with other pathogens, antibiotics using before sampling and influenza vaccination within previous year.